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Background: Many couples do not comply with fertility treatment 
because of its psychological burden. The SCREENIVF can be used to screen 
patients at risk for emotional maladjustment during treatment by assessing 
risk factors for maladjustment (distress, infertility cognitions and social 
support). The psychometric properties of the Portuguese version of the 
SCREENIVF were examined. This study also investigated if patients at risk 
for emotional maladjustment during fertility treatment reported lower 
intentions to comply with treatment than patients not at risk and which risk 
factors were associated with lower compliance intentions. 
Methods: Sample was composed of 383 infertile women and men 
undergoing any stage of fertility treatment in Portugal. They completed the 
Portuguese version of the SCREENIVF and other self-report questionnaires 
assessing wellbeing, partner support, child wish and intentions to comply 
with treatment.  
Results: Confirmatory factor analysis showed good fit of the 
SCREENIVF structural model. SCREENIVF presented good reliability and 
was significantly associated with other measures of distress, partner support 
and child wish. Patients at risk and not at risk for maladjustment reported 
similar compliance intentions. Negative associations found between distress 
and compliance intentions were moderated by patients’ cognitions regarding 
control perceived over fertility and its treatment and capacity to accept a 
future without biological children. 
Conclusion: The Portuguese version of the SCREENIVF is valid and 
reliable. Patients are overconfident about their ability to comply with 
treatment. Patients need to have information and feel control over treatment 
in order to make informed and satisfactory decisions about treatment uptake.  
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I – Conceptual framework 
Infertility affects 9% of couples worldwide (Boivin, Bunting, Collins, 
& Nygren, 2007) and 8.9% in Portugal (Silva- Carvalho & Santos, 2009). 
Chances of conceiving are high if infertile couples are willing to undergo 
repeated fertility treatment cycles (Pinborg, Hougaard, Andersen, Molbo, & 
Schmidt, 2009). However, a significant proportion of couples, ranging from 
34% (Rajkhowa, Mcconnell, & Thomas, 2006) to 60% (Malcom & 
Cumming, 2004) do not comply with recommended treatment, despite 
having good medical prognosis (Rajkhowa et al., 2006) and ability to cover 
treatment cost (Olivius, Friden, Borg, & Bergh, 2004; Verberg et al., 2008). 
Patients refer the psychological burden of fertility treatment as one of the 
main reasons to discontinue treatment (Brandes et al., 2009; Domar, Smith, 
Conboy, Iannonne, & Alper, 2010; Gameiro, Boivin, Peronace, & Verhaak, 
2012, in press; Olivius et al., 2004; Rajkhowa et al., 2006). Factors that 
increase patients’ psychological vulnerability to the burden of treatment may 
thus also affect patients’ willingness to comply with treatment. The main 
goal of the present study was to investigate if patients at risk for emotional 
maladjustment during fertility treatment reported lower intentions to comply 
with recommended treatment and which risk factors were associated to 
lower compliance intentions.  
The World Health Organization defines treatment adherence or 
compliance as “… the extent to which a person’s behaviour follows medical 
advice or corresponds with recommendations from the health care 
provider…” (WHO, 2003, p.3). In fertility care compliance refers to the 
uptake of all fertility treatments recommended by the medical team, ranging 
from first order treatments to Assisted Reproductive Technologies (ART), as 
long as there is ability to cover treatment costs (Boivin et al., 2012). Non-
compliance should be considered a negative outcome for patients and clinics 
alike. From the patients’ point of view, it represents giving up the goal of 
biological parenthood. For clinics non-compliance translates in lower 
pregnancy rates (Verhagen, Dumoulin, Evers, & Land, 2008), that is less 
effectiveness.  
Different studies show that patients identify the psychological distress 
of undergoing treatment as one of the main reasons for noncompliance. In 
the only prospective study that followed patients across their complete 
treatment pathway, 22% of patients reported that they did not comply with 
treatment because of the emotional distress treatment implied (Brandes et al., 
2009; Verberg et al., 2008). Patients cite psychological distress as a reason 
for not complying with treatment more often than other reasons such as 
financial issues (36% versus 23%) (Rajkhowa et al., 2006), physical burden 
(26% versus 6%) or marital problems/divorce (26% versus 15%) (Olivius et 
al., 2004). A recent systematic review of patients’ stated reasons for 
noncompliance showed that most reasons vary across stages (e.g., “Physical 
burden of treatments” during ART) but that psychological burden of 
treatment is cited at all stages (Gameiro et al., 2012). Taken together these 
data suggest that patients showing greater psychological vulnerability to 
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treatment may also present lower intentions to comply with it. 
Although patients cite the psychological burden of treatment as one of 
the most important reasons for noncompliance, empirical research in the 
field has not yet been able to identify which are the psychological risk 
factors behind noncompliance decisions (Gameiro et al., 2012). Fertility 
treatments can be highly demanding for couples. They involve complex 
medical procedures and the uncertainty about the success of each treatment 
attempt is high (Dunkel-Schetter & Lobel, 1991). These challenges can lead 
to states of high anxiety (Verhaak et al., 2007). Patients are also confronted 
with a long process of repeated decision-making (Cousineau & Domar, 
2007) and they state that the necessity to decide about uptake of further 
treatment can in itself be distressful (Peddie, van Teijlingen, & 
Bhattacharya, 2005). Highly anxious patients may cope with stress by 
avoiding treatment even when there is a good prognosis, which would reflect 
in lower intentions to comply with recommended treatment.  
The inability to conceive a child originates a sense of loss that can 
result in increased depressive symptoms (Dunkel-Schetter & Lobel, 1991), 
which can be accentuated by the experience of treatment failure (Verhaak, 
Smeenk, Evers, van Minnen, & Kraaimaat, 2005a). It is in this emotional 
context of loss and grief due to treatment failure, usually associated with less 
optimistic visions of the future (Beck, Rush, Shaw, & Emery, 1979) that 
patients need to decide about uptake of further treatment. In this context, 
more depressed patients may be less willing to comply with treatment. 
Patients’ cognitions about treatment and parenthood may also 
influence their compliance decision-making. Helplessness cognitions reflect 
a sense of lack of control over infertility and its treatment and are associated 
with higher distress after a failed treatment (Verhaak et al., 2005a), 
avoidance behaviours (Seligman, 1975) and limited capacity to make 
decisions (Rauprich, Berns, & Vollmann, 2011), possibly resulting in lower 
compliance. On the other hand, acceptance of a childless lifestyle can 
promote the pursue of other relevant life goals (e.g. profession, adoption) 
(van Balen, Verdurmen, & Ketting, 2006) and thus facilitate noncompliance. 
However, it is more likely that cognitions relate with compliance by 
conditioning the choices of more distressed patients. Highly distressed 
patients that feel helpless in relation to infertility and its treatment and who 
are more able to accept a childless lifestyle may be less willing to comply 
than those who are also highly distressed but still feel some control over 
treatment or cannot accept life without children.  
Social support is an important resource to cope with a low control 
stressor such as infertility (Jordan & Revenson, 1999) and the literature has 
shown that it is associated with a more adaptive response to failure in 
fertility treatment (Verhaak et al., 2005a). In the context of infertility, the 
spouse, family and friends are the most frequent sources of social support 
(Boivin, Scanlan, & Walker, 1999). Likewise, support groups may help 
couples because they offer the opportunity to experience communality 
(Lentner & Glazer, 1991 as cited in (Lemmens et al., 2004) and share 
relevant information (Aarts et al., 2012) about infertility and its treatments, 
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which should increase confidence and willingness to pursuit recommended 
treatment. 
Women show more intense emotional reactions to in vitro fertilization 
(IVF) treatments than men. They are subjected to more medical procedures 
and show higher physical fatigue during treatment (Boivin et al., 1998). At 
the same time, they seem less able to accept a childless lifestyle and to stop 
treatment than men (Wright, Bissonnette, & Duchesne, 1991). They are also 
more prone to seek social support to deal with their fertility problems 
(Boivin et al., 1998; Jordan & Revenson, 1999). It is thus expected that the 
associations between risk factors for psychological maladjustment and 
compliance will be different for women and men.  
In summary, patients’ emotional adjustment to treatment (i.e., anxiety 
and depression), their cognitions about infertility treatment and parenthood 
and the social support available may be associated with patients’ intentions 
to comply with treatment. These five factors were already identified as risk 
factors for a negative emotional response to the first (Verhaak et al., 2005a) 
and subsequent ART treatment cycles (Verhaak, Smeenk, van Minnen, 
Kremer, & Kraaimaat, 2005b). Based on these five risk factors, Verhaak and 
colleagues (Verhaak, Lintsen, Evers, & Braat, 2010) developed the 
SCREENIVF, the first screening tool specific for fertility care that aims to 
identify women at risk for maladjustment during ART. Cut-off scores that 
indicate clinical relevant problems were established for each risk factor. The 
tool classifies women as at risk for emotional problems when their scores 
indicate that they are at risk for at least one of the five risk factors. The 
SCREENIVF was tested on a sample of 279 women and proved to be an 
effective tool to differentiate women entering IVF treatment who later 
presented or not clinical relevant psychological problems during treatment. 
In addition, a study conducted in The Netherlands showed that the use of the 
SCREENIVF tool in the clinic context is feasible. More specifically, it 
showed that 78% of patients who were requested to fill the SCREENIVF 
actually did it and that this allowed identifying patients at risk for emotional 
problems (approximately 30%). Patients found the SCREENIVF instructions 
easy to understand and stated that the length of the questionnaire was 
acceptable (Van Dongen, Kremer, Van Sluisveld, Verhaak, & Nelen, 2011). 
Taken together, these data suggest that the SCREENIVF may constitute an 
important and useful tool for patients and clinics alike. However, only its 
Dutch version has been validated (Verhaak et al., 2010) and its reliability 
and validity have not been investigated in men or patients undergoing less 
advanced treatment stages than ART.  
II - Goals 
The main purpose of the present study was to investigate if patients 
identified as at risk for emotional maladjustment during fertility treatment 
were also at higher risk for not complying with treatment. Specific goals 
were to: (1) investigate the psychometric properties of the Portuguese 
version of the SCREENIVF tool (i.e., construct validity, reliability and 
discriminant validity) in a sample of infertile women and men undergoing 
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any stage of fertility diagnosis or treatment in Portugal; (2)  investigate if 
patients identified by the SCREENIVF as at risk for emotional 
maladjustment reported lower intentions to comply with treatment; (3) 
investigate associations between the SCREENIVF risk factors and patients’ 
intentions to comply with treatment; (4) investigate if cognitions about 
treatment and parenthood (i.e. helplessness and acceptance) moderated 
associations between anxiety and depression and patients’ intentions to 
comply with treatment and (5) investigate if such relationships were 
moderated by gender.  
III – Methods 
1. Procedures 
The study was approved by the Ethics Committee of the Coimbra 
University Hospitals.  
Participants were recruited online and at the clinical setting between 
January 2011 and February 2012. Inclusion criteria were being adult and 
undergoing fertility diagnosis or treatment at a fertility clinic in Portugal. 
Online recruitment was done through a web based survey that was divulged 
in the APFertilidade website, the main patient advocacy group in Portugal. A 
Facebook cause was also created and divulged among all APFertilidade 
Facebook friends. The clinic setting consisted of a large university based 
hospital where individuals were systematically invited to participate in the 
study. Individuals could choose between four ways to participate: (1) fill the 
questionnaire at the hospital and return it to the research team; (2) take the 
questionnaire home and return it during the following consultation at the 
hospital; (3) take the questionnaire home and return it to the research team 
by post mail in a pre-addressed envelope; (4) complete the questionnaire on-
line. In the three later cases, if patients did not return or filled online the 
questionnaires, a reminder text message was sent two and four weeks after. 
All participants signed an informed consent and confidentiality was 
guaranteed. Figure 1 of supplemental material presents the sample collection 
flowchart. At the clinical setting, 478 patients were invited to participate and 
233 delivered the questionnaire. Two hundred and twenty two questionnaires 
were submitted online. Of these, nine were excluded because were 
duplicates. In total 446 questionnaires were delivered. From these, only 
those where 80% of the SCREENIVF was filled were retained and 12 were 
excluded because they were identified as outliers 
 
2. Materials 
Socio-demographic (e.g., age, educational level) and clinical (e.g., 
duration of infertility, stage of treatment) background characteristics were 
assessed with a self-report questionnaire. 
Risk for emotional maladjustment was assessed with the SCREENIVF 
tool (Original Version: Verhaak, Lintsen, Evers, &Braat, 2010; Portuguese 
Version: Gameiro, &Canavarro, 2011). The SCREENIVF is composed of 34 
items organized in five dimensions that assess risk for maladjustment.  The 
Anxiety dimension (10 items, e.g., “I get very nervous and worried when 
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thinking about my current troubles”) was based on a short version of the 
Spielberger State and Trait Anxiety Inventory (Spielberger, 1983). The 
Depression dimension (7 items, e.g., “I feel sad”) was based on the Beck 
Depression Inventory, version for patients of general practitioners (Beck, 
Guth, Steer, & Ball, 1997). Helplessness (6 items, e.g., “My fertility 
problems control my life”) and Acceptance cognitions (6 items, e.g., “I can 
accept my fertility problems”) were assessed with items from the Illness 
Cognition Questionnaire for IVF patients (Evers, Kraaimaat, Lankveld, 
Jongen, & Biijlsma, 2001; Verhaak et al., 2005b). The Social Support 
dimension (5 items, e.g., “When I feel sad there is always someone I can talk 
to”) was composed by items derived from the Inventory of Social 
Involvement (van Dam-Baggen & Kraaimaat, 1992). The original version of 
the SCREENIVF exhibited excellent reliability in all scales (Cronbach’s 
alphas between .82 and .92). Based on patients’ scores on the five risk 
factors, the tool classifies patients as “at risk” or “not at risk” for emotional 
maladjustment. The SCREENIVF correctly identified 69% of the total of 
patients who presented clinical significant emotional difficulties and 77% of 
those who did not (Verhaak et al., 2010). To develop the Portuguese version 
of the SCREENIVF, we followed (Humbleton, Merenda, & Spielberg,(2005) 
recommendations’ for adapting tests. To classify individuals as at risk, we 
followed the procedures described by Verhaak et al. (2010). The cut-off 
score for depression was four or higher, which is in line with previous 
studies (Beck et al., 1997; Verhaak et al., 2010). For anxiety, helplessness 
and acceptance cognitions and social support, scores were based on one 
standard deviation above or below the sample mean scores. Thus, cut-off 
score for anxiety was 27 or above; for helplessness cognitions was 15 or 
above; for acceptance cognitions was 11 or below; and for social support 
was 13 or below. In each of the five risk factors, if patients scored 
above/below the cut-off point, it was assigned to them a score of 1 (at risk); 
otherwise, it was 0 (not at risk). Patients are classified as “at risk” if they are 
at risk in at least one of the five risk factors. 
Anxiety and depression were assessed with the anxiety (6 items, e.g., 
“I feel tense or nervous”) and depression (6 items, e.g., “I'm not too 
pessimistic or feel discouraged about the future”) scales of the Brief 
Symptom Inventory (Original Version: Derogatis, 1982; Portuguese 
Version: Canavarro, 1995) which have a 5-point Likert scale ranging from 0 
(Never) to 4 (Very often). Total scores correspond to the sum of the scale 
items and range from 0 to 24, with higher scores indicating more symptoms. 
The Portuguese version of the BSI is sound (Canavarro, 1995). Cronbach’s 
alpha values in the present sample were of .89 for both dimensions. 
Quality of life was assessed with the Fertility Quality of Life tool 
(FertiQol; Original Version: Boivin,  Takefman, &Braverman, 2011; 
Portuguese Version Gameiro, & Canavarro, 2010). FertiQol is composed of 
24 items organized in four quality of life domains: emotional (6 items, e.g., 
“Do your fertility problems cause feelings of jealousy and resentment?”), 
mind-body (6 items, e.g., “Are your attention and concentration impaired by 
thoughts of infertility?”), relational (6 items, e.g., ”Have fertility problems 
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strengthened your commitment to your partner?”) and social (6 items, e.g., 
“Do you feel social pressure on you to have (or have more) children?”). 
Total scores range from 0 to 100, with higher scores indicating higher 
quality of life. The Portuguese version of the FertiQoL has good 
psychometric characteristics (Melo, Gameiro, & Canavarro, in press). In the 
present sample Cronbach’s alpha values varied from .71 to .90. 
Relational adjustment was assessed with the Revised Dyadic 
Adjustment Scale (RDAS; Original Version: Busby, Christensen, Crane, & 
Larson, 1995; Portuguese Version: Pereira, Canavarro, & Davide, 2009). 
This scale is composed of 14 items (e.g., “How often do you discuss or have 
you considered divorce, separation, or terminating your relationship?”) that 
assess satisfaction with an intimate relationship. The total score ranges from 
0 to 69. Higher scores reflect higher relational adjustment. Cronbach’s alpha 
value for the total scale was .82. 
Partner support was assessed with one single item constructed by the 
researchers. Individuals had to rate on a 5-point Likert scale ranging from 1 
(Never) to 5 (Always) the degree to which the sentence “Do you feel support 
and understanding from your partner in relation to your fertility problems 
and fertility treatments?” described their experience. 
Child wish was assessed by a unique question, assessing the extent to 
which the participant wanted to have a child, with a response scale ranging 
from 0 (No desire) to 10 (Very strong desire). 
Compliance intentions were assessed with the FertiQoL persistence 
scale (Boivin, Takefman, & Braverman, 2011). This scale is composed of 
six item (e.g., “How often do you consider withdrawal from treatment?”), 
with a 5-point Likert answering scale ranging from 1 (Never) to 5 (Always), 
assessing patient’s motivation to persist in treatment. Scores vary from 6 to 
30, with higher scores indicating stronger intentions to do more treatments. 
In the present sample Cronbach’s alpha value was .77. 
 
3. Data analysis 
The psychometric properties of the SCREENIVF investigated were 
construct validity, reliability and discriminant validity. 
Construct validity was examined through Confirmatory Factor 
Analysis (CFA) and by testing the criterion validity of the five risk factors. 
The CFA was performed using AMOS, version 17.0, to test the structure of 
the SCREENIVF tool. The model was a first-order model with five latent 
variables that correspond to the five risk factors for emotional 
maladjustment. For each of the dimensions of the SCREENIVF, three 
parcels were generated by randomly combining the items of that dimension 
(Little, Cunningham, Shahar, & Widaman, 2002), a statistical procedure that 
is known to ameliorate model fit and to produce less bias in the estimation of 
structural parameters (Bandalos, 2002). To assess model fit different 
parameters commonly used were analysed: X
2
, the comparative fit index 
(CFI) and the root-mean-square error of approximation (RMSEA) (Byrne, 
2010). A model is considered to have very good fit if the X
2
 value is non-
significant (p > .05), the CFI is greater than .95 and the RMSEA is less than 
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.06 (Hu & Bentler, 1998).To investigate if the SCREENIVF can be used 
with different groups of patients its measurement (associations of observed 
scores to the latent variables) and structural (associations of latent variables 
with each other) invariance was tested across gender and treatment stage 
(first order treatments versus ART). Invariance in the model occurs when the 
X
2
 difference between the tested models is non-significant (Byrne, 2010) or 
the CFI difference is smaller than <.01 (Cheung & Rensvold, 2002). 
Criterion validity of the SCREENIVF was tested through the investigation of 
the correlations between the different SCREENIVF risk factors and between 
these and other measures of anxiety and depression, relational adjustment, 
partner support and child whish. 
The reliability (internal consistency) of the SCREENIVF was 
investigated using Cronbach’s alpha and by analysing the correlations 
between each item and its specific dimension. Finally, discriminant validity 
was examined using multivariate analysis of variance (Manova) to 
investigate if patients classified as at risk for maladjustment reported worse 
wellbeing (i.e., higher anxiety and depression and lower quality of life and 
relational adjustment) than patients not at risk. 
To investigate if patients identified by the SCREENIVF as at risk for 
emotional maladjustment reported lower intentions to comply with treatment 
than patients not at risk we used univariate analysis of variance (Anova).  
Finally, to investigate how the five risk factors were associated with 
intentions to comply with treatment, one hierarchical linear regression was 
performed. Firstly, any socio-demographic or clinic characteristics that were 
associated with patients’ compliance intentions were entered in the first step 
of the model along with the five SCREENIVF dimensions and gender. In 
step two the interaction products between the five risk factors and gender 
were entered. In step three the four interaction terms between cognitions 
(helplessness and acceptance) and emotional adjustment (anxiety and 
depression) were entered. Finally, in the fourth step, three-way interactions 
of gender, cognitions and emotional adjustment were entered. Continuous 
variables were transformed into z-scores to avoid multicolinearity problems 
in the interaction products (Baron & Kenny, 1986). 
In all analyses where compliance intentions was the dependent 
variable we only considered a subgroup of 295 patients who were 
undergoing treatment at a public clinic and had done less than three 
IVF/ICSI (Intracytoplasmic Sperm Injection) cycles, thus assuring that 
patients met the legal criteria to access governmental funding for treatment 
in Portugal. 
IV - Results 
1. Participants 
The final sample was composed of 291 women and 92 men. Sample 
demographic and clinical characteristics are presented in Table 1. Both 
women and men were in their early thirties. Individuals were with their 
partners for an average of seven years. Women and men recruited at the 
clinical setting were significantly older than women and men recruited 
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online. Individuals recruited at the clinic context were less likely to attend 
college or university than individuals recruited online. The majority of 
participants did not have children (89.7%) and they were trying to get 
pregnant for an average of four years, having done on average 0.43 
intrauterine insemination (IUI) and 0.90 IVF treatment cycles. Participants 
recruited at the clinical context were more likely to be at less advanced 
stages of treatment and had done significantly less IVF treatments than 
individuals recruited online. 
 
Table 1. Mean (SD) or frequencies for sample socio-demographic and clinic characteristics (N = 383) 
Characteristics 
Total 
N= 383 
Online 
n = 182 
Clinic 
n = 201 
t/X2 
Socio-demographic     
     
Gender, n (%)    37.94 (1)*** 
Female 291 (76.00) 164 (90.10) 127 (63.20)  
Male 92 (24.00) 18 (9.90) 74 (36.80)  
Age (years), mean (SD) 33.50 (3.78) 33.01 (3.60) 33.95 (3.89) -2.46(1)* 
Female 33.06 (3.57) 32.92 (3.54) 33.24 (3.62)  
Male 34.90 (4.09) 33.78 (4.15) 35.18 (4.05)  
Relationship duration (years), 
mean (SD) 
7.07 (3.33) 6.91 (3.38) 7.21 (3.29) -0.89(1) 
Education     
Years of education, mean (SD) 13.39 (3.92) 15.01 (3.53) 11.50 (3.48) 8 .78(1)*** 
College or University 
Education, n (%) 
   39.59 (1)*** 
No 197 (52.00) 63 (35.00) 134 (67.30)  
Yes 182 (48.00) 117 (65.00) 65 (32.70)  
Socioeconomic status, n (%)    0.28(2)*** 
Low 141 (37.40) 43 (23.80) 98 (50.00)  
Medium 203 (53.80) 115 (63.50) 88 (44.9)  
High 33 (8.80) 23 (12.7) 10 (5.10)  
Religion, n (%)    8.76 (1)** 
Catholic 311 (85.67) 132 (80.98) 179 (89.50)  
Other 10 (2.75) 3 (1.84) 7 (3.50)  
None 42 (11.58) 28 (17.18) 14 (7.00)  
Residence zone, n (%)    77.70 (1)*** 
Urban 244 (64.20) 156 (87.20) 88 (43.80)  
Rural 136 (35.80) 23 (12.80) 113 (56.20)  
Clinic     
Infertility duration (years), mean 
(SD) 
4.30 (2.51) 4.21 (2.60) 4.37 (2.44) -0.59(1) 
Number of previous treatments, 
mean (SD) 
    
IUI 0.43 (1.03) 0.49 (1.20) 0.37 (0.84) 1.07(1) 
IVF/ICSI 0.90 (1.38) 1.26 (1.61) 0.56 (0.90) 5.11(1)*** 
Children, n (%)    0.30(1) 
No 341 (89.70) 159 (88.80) 182 (90.50)  
Yes 39 (10.30) 20 (11.20) 19 (9.50)  
Current treatment stage, n (%)    0.22(2)** 
Exams 101 (26.90) 42 (23.10) 59 (30.60)  
Taking medication / injections 68 (18.10) 23 (12.60) 45 (23.30)  
IUI 24 (6.40) 13 (7.10) 11 (5.70)  
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Waiting to start IVF 56 (14.90) 38 (20.90) 18 (9.30)  
IVF/ICSI 126 (33.60) 66 (36.30) 60 (31.10)  
Note: * p< .05. ** p< .01. *** p< .001.IUI = Intrauterine insemination; IVF = In vitro fertilization; ICSI = 
Intracytoplasmic sperm injection (1) Student’s t-test. . (2) Cramer’s V.  
 
2. Psychometric properties of the SCREENIVF 
2.1. Construct validity 
Figure 2 of supplemental material presents standardized estimates for 
measurement and structural paths of the tested model. The X
2
 value of the 
model was significant (X
2
(80) = 188.50; p<.001). The indexes values were 
very good and good, respectively: CFI = 0.97; RMSEA = 0.06 [confidence 
interval (CI) 90% 0.05-0.07]; (Hu & Bentler, 1998). All the standardized 
factor loadings of the item parcels into their correspondent latent construct 
were statically significant (p < .001) and higher than .75.Table 2 presents 
results of the test of the measurement and structural invariance of the 
SCREENIVF. Results indicate that the SCREENIVF was invariant across 
treatment stages. Significant structural variance was observed for gender. 
 
Table 2. Results of multigroup analysis testing the measurement and structural invariance of SCREENIVF 
  X2 Df RMSEA CIF ΔX2 Δdf ΔCFI 
Gender        
Unconstrained 296.02 160 .05 (.04 .06) .965    
Measurement invariance  326.81 170 .05 (.04 .06) .960 30.79*** 10 .005 
Structural invariance 382.845 185 .05 (.05 .06) .949 86.83*** 25 .016 
Treatment stage        
Unconstrained 277.078 160 .04 (.04 .05) .970    
Measurement invariance 287.246 170 .04 (.03 .05) .970 10.17 10 .000 
Structural invariance 306.297 185 .0 (.03 .05) .969 29.22 25 .001 
Note: * p< .05, ** p< .01, ***p < .001; Df = degrees of freedom, RMSEA = root-mean-square error of approximation, 
CIF = comparative fit index, ΔX2 = X2 change, Δdf = degrees of freedom change, ΔCFI =comparative fit index change 
 
Table 3 presents associations between the different SCREENIVF 
dimensions and between these and other measures of anxiety and depression, 
relational adjustment, partner support and child wish. Anxiety and 
depression were positively associated with helplessness cognitions and 
negatively associated with acceptance cognitions and social support. Social 
support was negatively associated with helplessness cognitions and 
positively associated with acceptance cognitions. Finally, helplessness 
cognitions were negatively associated with acceptance cognitions. 
Associations between the different dimensions of the SCREENIVF and 
measures of anxiety and depression, relational adjustment, partner support 
and child wish were as expected. Anxiety and depression, as measured with 
the SCREENIVF, were more strongly related with the BSI subscales of 
anxiety and depression. Social support was more strongly related with 
anxiety and depression and partner support. Helplessness and acceptance 
cognitions were more strongly related with child wish. 
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Table 3. Correlations between the SCREENIVF risk factors and anxiety and depression, relational adjustment, 
partner support and child wish 
 
Mean (SD) 
n (%) 
At risk 
SCREENIVF 
 
Anxiety Depression Helplessness 
cognitions 
Acceptance 
cognitions 
Social 
support 
SCREENIVF         
Anxiety 20.87 (6.28) 70 (18.40) 1     
Depression 2.51 (3.09) 106 (28.10) .70** 1    
Helplessness 
cognitions 
11.10 (4.29) 83 (21.70) .62** .65** 1   
Acceptance 
cognitions 
15.68 (4.68) 70 (18.30) -.58** -.51** -.55** 1  
Social support 16.48 (3.70) 70 (18.30) -.37** -.39** -.27** .32** 1 
TOTAL --- 180 (47.00)      
Total women  152 (52.20)      
Total men  28 (30.40)      
        
Anxiety BSI  5.73 (5.07)  .63** .61** .58** -.46** -.28** 
Depression BSI 4.76 (5.11)  .65** .72** .59** -.52** -.27** 
Relational 
adjustment 
54.41 (7.42)  -.34** -.32** -.17** .26** .41** 
Partner support  4.50 (.94)  -.31** -.25** -.21** .15** .24** 
Child wish 9.52 (.97)  .16** .13** .19** -.20** -.04** 
Note: ** p <.01; * p< .05; SD = standard deviation.     
 
2.2. Reliability 
Table 1 of supplemental material shows mean and standard-deviation 
values for each item, item-subscales correlations, Cronbach’s alpha values if 
the item was deleted and Cronbach’s alpha values for each subscale (for 
women and men).The correlations item-subscale values varied from .45 (“ I 
worry too much about not really important things”, anxiety subscale) to .92 
(“When I am sad there is someone to talk about”, social support subscale), 
indicating that all items adequately represent the concept that each subscale 
measures (Cohen, 1992). Cronbach’s alpha varied from .85 (Depression) to 
.93 (Acceptance cognitions) for women and between .66 (Depression) and 
.91 (Social support) for men. This means that all dimensions had good 
internal consistency, excepting Depression for men, that is not considered 
appropriate (Kline, 1999; as cited in (Field, 2006). 
 
2.3. Discriminant validity 
The SCREENIVF did not present structural invariance across gender 
and so its discriminant validity was tested separately for women and men. 
Table 4 shows differences between women and men classified as at risk and 
not at risk in terms of wellbeing. Results showed that women and men 
identified by the SCREENIVF as at risk for maladjustment reported worse 
wellbeing than women (F7, 237 = 28.68, ῃ
2
 = .46, p< .001Pillai’s trace = .46) 
and men (F7, 73 = 3.32, ῃ
2
 = .24, p = .004; Pillai’s trace =.24) not at risk.  
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Table 4. Differences between women and men classified as at risk and not at risk regarding wellbeing and 
intentions to comply with treatment 
 
Women Men 
 At risk 
n=124 
Not at risk 
n= 121 
   
At risk 
n = 22 
Not at risk 
n = 59 
  
          
 Mean SD Mean SD F ῃp
2  Mean SD Mean SD F ῃp2 
Wellbeing          
Anxiety 8.66 5.57 3.68 3.02 75.16*** .24  5.50 4.43 3.08 3.83 5.84* .07 
Depression 7.99 5.45 2.06 2.41 120.25*** .33  5.20 3.98 2.69 4.49 5.32* .06 
Quality of 
Life 
             
Emotional 45.13 18.75 71.80 15.08 150.11*** .38  65.72 14.02 80.22 15.57 16.20*** .17 
Mind-
Body 
49.03 21.99 75.70 16.96 112.62*** .32  70.19 20.87 82.85 15.08 9.09** .10 
Relational 70.45 17.24 85.52 11.31 65.14*** .21  75.95 15.74 84.46 11.73 6.96* .08 
Social 54.45 20.47 76.52 14.99 92.32*** .28  73.07 15.87 80.44 12.51 4.79* .06 
Relational 
Adjustment 
51.68 7.94 57.06 6.33 34.30*** .12  51.82 6.89 56.10 6.39 6.90* .08 
 At risk 
n=104 
Not at risk 
n= 101 
   
At risk 
n = 25 
Not at risk 
n = 50 
  
          
 Mean SD Mean SD F ῃp
2  Mean SD Mean SD F ῃp2 
Intentions to 
comply with 
treatment 
23.98 4.16 24.84 4.32 2.11 .01  23.47 3.81 24.46 3.96 1.07 .01 
Note. *p<.05, **p<.01 *** p < .001, SD = Standard deviation, ῃp
2= partial eta squared     
 
Women and men classified as at risk for emotional maladjustment 
reported higher levels of anxiety and depression, worse quality of life across 
all domains (emotional, mind-body, relational and social) and worse 
relational adjustment. 
 
3. Differences between patients classified as at risk and not at risk 
for maladjustment regarding intentions to comply with treatment 
The SCREENIVF did not present structural invariance across gender 
and so these analyses were run separately for women and men. Table 4 
shows results for patients at risk and not at risk regarding their intentions to 
comply with treatment. Women and men at risk for maladjustment presented 
similar intentions to comply that women and men not at risk, respectively. 
 
4. Associations between risk factors for emotional maladjustment 
and intentions to comply with treatment 
Table 5 presents results from the hierarchic regression investigating 
predictors of patients’ intentions to comply with treatment. Age was 
negatively associated with patients’ intentions to comply with treatment. 
Significant effects were found for the interactions between helplessness 
cognitions and anxiety and helplessness cognitions and depression. Post hoc 
analysis for these interactions showed that for patients with low helplessness 
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cognitions, higher anxiety was associated with lower intentions to comply 
with treatment (β = -.45, p = .01). However, for patients with high 
helplessness cognitions, no significant association was found between 
anxiety and intentions to comply with treatment (β = .25, p = .13). 
Moreover, results showed that for patients with high cognitions of 
helplessness, higher depression was associated with lower intentions to 
comply with recommended treatment (β = -.33, p = .02). No association was 
not observed for patients with low helplessness cognitions (β = .19, p = .30). 
A significant effect for the three-way interaction between gender, 
acceptance cognitions and anxiety was also found. Post hoc analysis showed 
that for men the interaction between acceptance cognitions and anxiety was 
significant (β =-.53; p = .02), but for women it was not (β =.10; p = .46). For 
men with high levels of acceptance cognitions, higher anxiety was 
associated with lower intentions to comply with treatment (β = -.60; p = .03). 
On the other hand, for men with low levels of acceptance cognitions anxiety 
was not associated with their intentions to comply with treatment (β =.38; p 
= .21).  
 
Table 5. Hierarchic regression for intentions to comply with treatment (N = 274) 
Predictors B SE Β ΔF AdjR2 Δ R2 P 
        
Step 1     2.97 .05 .07 .005 
Age -.24 .07 -.22    .001 
Gender -.03 .74 -.00    .963 
Anxiety -.42 .45 -.10    .350 
Depression -.30 .50 -.07    .547 
Helplessness Cognitions .43 .45 .10    .343 
Acceptance Cognitions .13 .37 .03    .720 
Social support .06 .31 .01    .851 
        
Step 2    .41 .04 .01 .840 
Gender x Anxiety -.05 .94 -.01    .960 
Gender x Depression -.55 1.13 -.05    .628 
Gender x Helplessness cognitions .29 .84 .03    .735 
Gender x Acceptance cognitions -.62 .90 -.07    .491 
Gender x Social support .48 .66 .06    .464 
        
Step 3    1.22 .04 .02 .303 
Helplessness cognitions x Anxiety 1.47 .54 .44    .007 
Helplessness cognitions x Depression -1.09 .46 -.44    .019 
Acceptance cognitions  x Anxiety .41 .54 .10    .456 
Acceptance cognitions x Depression -.51 .56 -.16    .361 
        
Step 4    2.64 .07 .04 .035 
Gender x Helplessness cognitions x Anxiety -1.82 1.05 -.19    .082 
Gender x Helplessness cognitions x Depression 1.40 .94 .14    .138 
Gender x Acceptance cognitions  x Anxiety -2.47 1.04 -.30    .018 
Gender x Acceptance cognitions x Depression 2.90 1.51 .26    .056 
Note: B = b-values, SE = Standard Error, β = beta values, ΔF = F change, AdjR2= Adjusted R squared, ΔR2=R 
squared change. Bold indicates p < .05 
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V - Discussion 
The Portuguese version of the SCREENIVF proved valid and reliable 
to assess risk factors for emotional maladjustment. Women and men at risk 
for emotional maladjustment were equally willing to comply with treatment 
as those not at risk. Associations between patients’ distress (anxiety and 
depression) and their willingness to comply with it are conditioned by the 
degree of control patients perceive in relation to fertility and its treatments 
and their capacity to accept a future without biological children. 
Results from this study validated the measurement model of the 
SCREENIVF. The CFA showed that the five risk factors assessed by this 
instrument are independent but structurally related. In general, the subscales 
that assess the five risk factors presented good reliability and were related 
with other measures that assess similar constructs. Measurement invariance 
was ascertained across gender and treatment stage, indicating that the 
SCREENIVF items contribute equally to the assessment of each risk factor 
for all patients. This supports the use of one single cut-off score for 
classifying patients as at risk or not for emotional maladjustment, regardless 
of gender and treatment stage. These results show that the SCREENIVF is a 
valid and reliable tool to assess risk for emotional maladjustment to 
infertility treatment.  
Since the validity and the reliability of the Portuguese version of the 
SCREENIVF were good, we can expect its screening capacity to be similar 
to that of the original Dutch version (Verhaak et al., 2010). Although the 
SCREENIVF was firstly developed to screen women entering ART, the fact 
that it is invariant across treatment stages suggests that it can be applied to 
all women, regardless of the treatment stage they are undergoing (i.e., from 
diagnosis to ART). However, results of the CFA showed structural variance 
across gender, suggesting that the way in which the five risk factors 
associate is different for women and men. Implications for screening men 
are not clear and therefore need further investigation. Comparing with the 
original study of the SCREENIVF (Verhaak et al., 2010), our results show 
that more patients scored above the cut-off scores (i.e., classified as at risk) 
in terms of anxiety and depression (10% and 11% versus 18 and 28%, 
respectively). In the original study all participants were recruited in clinical 
context and therefore contacted personally with the research team. In our 
study, 48% of our sample was recruited online. Filling the questionnaire 
online may diminish social desirability bias because patients are anonymous, 
which may have resulted in more patients scoring above the cut-off scores. 
Another possibility is that online recruitment attracts patients who are highly 
involved in their treatment process and, consequently, more emotionally 
activated. Although the literature indicates that infertile patients recruited 
online are representative of their subpopulation (Schmidt 1997), further 
research is advisable to investigate if different cut off scores should be 
defined for clinical samples. 
Women and men identified by the SCREENIVF as at risk for 
emotional maladjustment presented lower individual and relational 
wellbeing than individuals classified as not at risk. This classification 
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identifies which individuals are at risk to develop clinically relevant mental 
health problems. However, results show that at the time they are classified as 
at risk they already present worse health status (e.g., lower quality of life). 
This fact supports the idea that patients at risk should receive additional 
psychosocial support (Verhaak et al., 2010). Such support has been regarded 
as preventive only, but our results suggest that it should already include 
strategies to increase wellbeing. 
 Women and men at risk were equally willing to comply with 
treatment as those not at risk. On average patients reported high intentions to 
comply with treatment (24 on a scale from 0 to 30). Additionally, only 10% 
of patients referred that they never or rarely though about continuing 
treatment, but research shows that noncompliance is a real phenomenon 
(Rajkhowa et al., 2006).These data suggest that patients may be 
overconfident about their ability to comply with treatment, as has already 
been observed in patients with other medical conditions that require 
demanding treatment such as breast cancer (Güth, Myrick, Kilic, 
Eppenberger-Castori, & Schmid, 2012).  These data suggests that patients 
should be informed from the start that fertility treatment is demanding and 
that some patients are not able to fully comply with recommendation. Such 
information may allow patients to prepare in advance to the challenges of 
treatment, for instance, by activating support from their social networks or 
seeking professional aid. 
Anxiety and depression were related with patients’ willingness to 
comply with treatment, but these relationships were conditioned by the 
degree of control patients perceive in relation to fertility and its treatments 
and their capacity to accept a future without biological children. While 
anxiety is an emotional reaction associated to the experience of treatment 
and uncertainty about its success, depression tends to result from the 
experience of treatment failure (Dunkel-Schetter & Lobel, 1991). These two 
situations present patients with different proactive decision-making: during 
treatment the proactive decision would be to stop treatment, while after a 
failed cycle the proactive decision would be to start another cycle. Results 
showed that only patients in control (i.e., low helplessness) were more 
willing to stop a treatment that was making them anxious and that only 
patients who had no control (i.e., high helplessness) were less willing to start 
another cycle when depressed. In summary, these results suggest that only 
patients in control are able to make proactive decisions. In this context, 
empowerment-oriented intervention can be helpful to reduce helplessness. 
The clinical staff can have an important role in promoting patients’ personal 
efficacy, competence and mastery regarding treatment related issues. 
Helplessness can also be avoided by involving patients in the treatment 
process and all associated decision-making (Israel, Checkoway, Schulz, & 
Zimmerman, 1994; Perkins & Zimmerman, 1995). Having control and 
information will allow patients to make more satisfying compliance 
decisions because they probably will better understand the implications and 
consequences of their decisions.  
Anxious men who accepted their infertility were less willing to 
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comply with treatment. No association between anxiety and compliance was 
found for men with low acceptance and for women. Indeed, as already 
stated, it is easier for men to accept their infertility, to stop treatment after 
repeated failure (Ulbrich, Tremagliocoyle, &Llabre, 1990; as cited in(Webb 
& Daniluk, 1999) and to focus on other activities (Wright et al., 1991). This 
means that women and men cope differently with stress and this reflects in 
their compliance intentions, possibly triggering intra-couple strain. In this 
context, decisional-aid about treatment uptake should be directed at both 
members of the couple and integrate life and relationship values clarification 
techniques (Gameiro et al, 2012). Such an approach may help both members 
of the couple to reconcile their individual perspectives and lead to a final 
compliance decision that is satisfactory for both. 
This study presented methodological limitations that must be 
considered. First, the sample included a small number of men. While the 
overall and women only sample size ensured enough power to detect small 
to medium effect sizes in multivariate analysis (p< .05, power = .80, effect 
size from .05 to .09), for men only medium to large effect sizes could be 
detected (p< .05, power = .80, effect size = .33) (Faul, Erdfelder, Lang, & 
Buchner, 2007), which means that some associations might have not been 
detected. Therefore, more research should be conducted to investigate if and 
how the SCREENIVF should be used with men. Second, 48% of participants 
were recruited online and differences between participants recruited online 
and in clinical setting were observed. Although the literature indicates that 
data collected through online recruitment is valid (Lieberman, 2008) one 
would need to determine whether the differences observed may have 
implications as, for instance, in the definition of cut-off scores for 
classifying individuals as at risk for maladjustment. Third, we did not test 
the screening properties of the Portuguese version of the SCREENIVF. 
Thus, and although we can expect its screening capacity to be similar to that 
of the original Dutch version (Verhaak et al., 2010), longitudinal research for 
this purpose is still required. Finally, although we investigated risk factors 
for women and men, we did not investigate how the psychopathological 
vulnerability of one couple’s member may affect the other member and the 
couples’ compliance behavior, which should also be the subject of future 
research. 
VI - Conclusion 
The Portuguese version of the SCREENIVF proved to be valid and 
reliable, meaning that it can be used with women undergoing any stage of 
fertility treatment. Further investigation is needed to attest its usefulness 
with men. The use of the SCREENIVF will allow professionals to identify 
which patients need and benefit more from psychosocial support to increase 
wellbeing and prevent future emotional difficulties.  Clinics need to ensure 
that couples have the necessary conditions to make satisfactory and informed 
decisions about treatment uptake. For the effect, patients need to have 
control over their treatment and may benefit from a moderated environment 
to discuss treatment alternatives with their partners. 
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Figure 1. Sample collection procedures 
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Figure 2. Standardized regression weights of factor loadings. Note: E, error, P, parcel 
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 Mean SD Correlation 
item-
subscale 
Cronbach’s 
alpha if 
item 
deleted 
Cronbach’s 
Alpha 
Women 
Cronbach’s 
Alpha Men 
Anxiety 20.87 6.28   .90 .87 
I feel fine 1.96 0.85 .78** .88   
I feel satisfied 2.21 0.87 .77** .88   
I worry too much about not really 
important things 
2.26 0.87 .45** .91   
I am happy 1.99 0.87 .74** .88   
I am troubled by disturbing thoughts 1.97 0.89 .73** .89   
I feel safe 2.19 0.90 .70** .89   
I am pleased 2.04 0.80 .77** .88   
There are thoughts that keep hauting me 2.04 0.88 .73** .89   
I take my disappointments so seriously 
that I cannot get them out of my mind 
1.95 0.92 .78** .88   
I get very nervous and worried when 
thinking about my current problems 
2.30 0.90 .75** .89   
Depression 2.51 3.09   .85 .66 
I feel sad 0.49 0.71 .79** .81   
I'm not too pessimistic or feel 
discouraged about the future 
0.46 0.64 .66** .83   
I do not have the feeling of having failed 0.46 0.75 .80** .81   
I'm not unhappy with anything in 
particular 
0.40 0.63 .77** .81   
I am not displeased with me 0.21 0.48 .77** .81   
I do not feel any worse than anyone else 0.37 0.65 .67** .83   
I have no thoughts of harming myself 0.06 0.32 .49** .85   
Social Support 16.48 3.70   .92 .91 
When I feel tense or nervous, there is 
someone to help me 
3.20 0.90 .87** .90   
When I experience some nice things, 
there is someone to talk about 
3.49 0.73 .85** .90   
When I am in pain there is someone to 
comfort me 
3.31 0.87 .91** .88   
When I am sad there is someone to talk 
about 
3.28 0.86 .92** .88   
When I need help with a job I cannot 
carry out alone there is someone to help 
me 
3.19 0.89 .79** .93   
Acceptance cognitions 15.68 4.68   .93 .88 
I deal with the consequences of me 
fertility problems 
2.72 0.87 .81** .92   
I have learned to live with my fertility 
problems 
2.75 0.90 .88** .90   
I have learned to accept my fertility 
problems 
2.59 0.95 .85** .91   
I can accept my fertility problems 2.61 0.95 .87** .90   
I think I can cope with my fertility 
problems even if they are not solved 
2.47 0.91 .80** .92   
I can cope with well with my fertility 
problems 
2.53 0.95 .86** .91   
Helplessness cognitions 11.10 4.29   .87 .80 
Because of my fertility problems , I miss 1.70 0.85 .71** .86   
Table 1. Correlations between each subscale and its items 
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the things that are most important for me 
My fertility problems control my life 1.79 0.94 .81** .84   
My fertility problems sometimes give me 
the feeling of being useless 
1.78 0.98 .80** .84   
My fertility problems make my life 
incomplete 
2.48 1.02 .79** .85   
My fertility problems affect everything 
that is important for me 
1.74 0.89 .84** .83   
I often feel helpless because of my 
fertility problems 
1.60 0.83 .72** .86   
Note: ** p <.01       
 
